▶ 調査レポート

淋病治療法の世界市場:淋菌感染症別、治療別、投与経路別、性別

• 英文タイトル:Gonorrhea Therapeutics Market (Gonococcal Infection: Uncomplicated Gonococcal Infection, Gonococcal Arthritis, Gonococcal Meningitis, and Endocarditis; Treatment: Monotherapy and Dual Therapy; Route of Administration: Oral and Injectable; Gender: Women and Men; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Gonorrhea Therapeutics Market (Gonococcal Infection: Uncomplicated Gonococcal Infection, Gonococcal Arthritis, Gonococcal Meningitis, and Endocarditis; Treatment: Monotherapy and Dual Therapy; Route of Administration: Oral and Injectable; Gender: Women and Men; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027「淋病治療法の世界市場:淋菌感染症別、治療別、投与経路別、性別」(市場規模、市場予測)調査レポートです。• レポートコード:TPM-NV041
• 出版社/出版日:Transparency Market Research / 2019年9月
• レポート形態:英文、PDF、186ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥799,710 (USD5,795)▷ お問い合わせ
  Multi User¥1,213,710 (USD8,795)▷ お問い合わせ
  Global Site License¥1,627,710 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、淋病治療法の世界市場について調べ、淋病治療法の世界市場規模、市場動向、市場シェア、市場環境、市場予測、淋菌感染症別(合併症のない淋菌感染症、淋菌性関節炎、淋菌性髄膜炎、および心内膜炎)分析、治療別(単独療法&二重療法)分析、投与経路別(経口および注射)分析、性別(女性、男性)分析、関連企業情報などをまとめました。
・淋病治療法の市場概要
・淋病治療法の市場動向
・淋病治療法の世界市場規模・予測
・淋病治療法市場:淋菌感染症別(合併症のない淋菌感染症、淋菌性関節炎、淋菌性髄膜炎、および心内膜炎)
・淋病治療法市場:治療別(単独療法&二重療法)
・淋病治療法市場:治療別(単独療法&二重療法)
・淋病治療法市場:性別(女性、男性)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

Gonorrhea Therapeutics Market – Scope of the Study

[186 Pages Report] Transparency Market Research (TMR), in its latest business study, identifies significant growth opportunities present in the gonorrhea therapeutics market for the forecast period of 2019-2027. The comprehensive business study traces significant trends and recent developments encircling the gonorrhea therapeutics landscape. In addition, it provides intelligent industry insights into the gonorrhea therapeutics market by lending an incisive assessment of the key drivers, restraints, threats, and opportunities.

This comprehensive business study offers a detailed assessment of the demand and supply chain in the gonorrhea therapeutics market. This exclusive guide determines the macroeconomic as well as microeconomic parameters that help in comprehending the growth of the gonorrhea therapeutics market during the forecast period.

The gonorrhea therapeutics market size has been evaluated in terms of value (US$ Mn). Information included in this exhaustive research report can aid stakeholders in the gonorrhea therapeutics market in determining profitable growth opportunities for their business advancement.

This exclusive research report also uncovers an in-depth SWOT assessment of the leading, prominent, and emerging market players operating in the gonorrhea therapeutics market. This assessment will aid stakeholders gain an incisive perspective apropos of the growth of the gonorrhea therapeutics market.

This in-depth business guide assesses and includes Porter’s Five Forces to provide key growth strategies present in the gonorrhea therapeutics market during the forecast period. This exclusive guide provides key information about the competition present in the gonorrhea therapeutics market by identifying key competitors. The exclusive report also includes key strategies, financials, and notable developments present in the gonorrhea therapeutics market during the forecast period of 2019-2027.

Gonorrhea Therapeutics Market – Key Questions Answered

An exclusive business study published by Transparency Market Research (TMR) offers intelligent insights apropos of the growth of the gonorrhea therapeutics market, through which stakeholders operating in the market can gain an edge over their competitors. Authors of the report assess the gonorrhea therapeutics market, and provide data and numbers demonstrating the impact of the influential trends and key developments in the industry. The global study addresses the key questions of stakeholders in the gonorrhea therapeutics market.

What are the recent developments and market shifts observed in the gonorrhea therapeutics market?
What are the key winning imperatives for leading and prominent players functioning in the gonorrhea therapeutics market?
What are the significant trends stimulating the growth of the gonorrhea therapeutics market?
Which distribution channel will draw significant sales in the gonorrhea therapeutics market?
Gonorrhea Therapeutics Market – Research Methodology

Research carried out by analysts at TMR includes a robust research approach that includes both, primary and secondary research. In order to carry out primary research, discussions were scheduled with distributors, industry experts, vendors, and key opinion leaders. This significantly helps in assessing the demand-supply gap in the gonorrhea therapeutics market.

For carrying out secondary research, company websites, marketing collaterals, press releases, industry associations, and statistics presented by government websites were referred to.

Gonorrhea Therapeutics Market – Segmentation

In order to present an incisive view of the gonorrhea therapeutics market, analysts and researchers of the report have segregated the gonorrhea therapeutics market based on the gonococcal infection, treatment, route of administration, gender, distribution channel, and region. This comprehensive business study also analyzes the incremental opportunity present in the gonorrhea therapeutics market during the forecast period.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Gonorrhea Therapeutics Market

4. Market Overview

4.1. Introduction

4.1.1. Gonococcal Infection Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Gonorrhea Therapeutics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Regulatory Scenario by Region/globally

5.2. Reimbursement Scenario by Region/globally

6. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Gonococcal Infection Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017–2027

6.3.1. Uncomplicated Gonococcal Infection

6.3.2. Gonococcal Arthritis

6.3.3. Gonococcal Meningitis and Endocarditis

6.4. Global Gonorrhea Therapeutics Market Attractiveness, by Gonococcal Infection Type

7. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Treatment

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Gonorrhea Therapeutics Market Forecast, by Treatment, 2017–2027

7.3.1. Monotherapy

7.3.2. Dual Therapy

7.4. Global Gonorrhea Therapeutics Market Attractiveness, by Treatment

8. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Route of Administration

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017–2027

8.3.1. Oral

8.3.2. Injectable

8.4. Global Gonorrhea Therapeutics Market Attractiveness, by Route of Administration

9. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Gender

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Global Gonorrhea Therapeutics Market Forecast, by Gender, 2017–2027

9.3.1. Women

9.3.2. Men

9.4. Global Gonorrhea Therapeutics Market Attractiveness, by Gender

10. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Distribution Channel

10.1. Introduction & Definition

10.2. Key Findings / Developments

10.3. Global Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017–2027

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.3.4. Others

10.4. Global Gonorrhea Therapeutics Market Attractiveness, by Distribution Channel

11. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Region

11.1. Key Findings

11.2. Global Gonorrhea Therapeutics Market Forecast, by Region

11.2.1. North America

11.2.2. Europe

11.2.3. Asia Pacific

11.2.4. Latin America

11.2.5. Middle East & Africa

11.3. Global Gonorrhea Therapeutics Market Attractiveness, by Region

12. North America Gonorrhea Therapeutics Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. North America Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017–2027

12.2.1. Uncomplicated Gonococcal Infection

12.2.2. Gonococcal Arthritis

12.2.3. Gonococcal Meningitis and Endocarditis

12.3. North America Gonorrhea Therapeutics Market Forecast, by Treatment, 2017–2027

12.3.1. Monotherapy

12.3.2. Dual Therapy

12.4. North America Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017–2027

12.4.1. Oral

12.4.2. Injectable

12.5. North America Gonorrhea Therapeutics Market Forecast, by Gender, 2017–2027

12.5.1. Women

12.5.2. Men

12.6. North America Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017–2027

12.6.1. Hospital Pharmacies

12.6.2. Retail Pharmacies

12.6.3. Online Pharmacies

12.6.4. Others

12.7. North America Gonorrhea Therapeutics Market Forecast, by Country, 2017–2027

12.7.1. U.S.

12.7.2. Canada

12.8. North America Gonorrhea Therapeutics Market Attractiveness Analysis

12.8.1. By Gonococcal Infection Type

12.8.2. By Treatment

12.8.3. By Route of Administration

12.8.4. By Gender

12.8.5. By Distribution Channel

12.8.6. By Country

13. Europe Gonorrhea Therapeutics Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Europe Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017–2027

13.2.1. Uncomplicated Gonococcal Infection

13.2.2. Gonococcal Arthritis

13.2.3. Gonococcal Meningitis and Endocarditis

13.3. Europe Gonorrhea Therapeutics Market Forecast, by Treatment, 2017–2027

13.3.1. Monotherapy

13.3.2. Dual Therapy

13.4. Europe Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017–2027

13.4.1. Oral

13.4.2. Injectable

13.5. Europe Gonorrhea Therapeutics Market Forecast, by Gender, 2017–2027

13.5.1. Women

13.5.2. Men

13.6. Europe Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017–2027

13.6.1. Hospital Pharmacies

13.6.2. Retail Pharmacies

13.6.3. Online Pharmacies

13.6.4. Others

13.7. Europe Gonorrhea Therapeutics Market Forecast, by Country/Sub-region, 2017–2027

13.7.1. Germany

13.7.2. U.K.

13.7.3. France

13.7.4. Spain

13.7.5. Italy

13.7.6. Rest of Europe

13.8. Europe Gonorrhea Therapeutics Market Attractiveness Analysis

13.8.1. By Gonococcal Infection Type

13.8.2. By Treatment

13.8.3. By Route of Administration

13.8.4. By Gender

13.8.5. By Distribution Channel

13.8.6. By Country

14. Asia Pacific Gonorrhea Therapeutics Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017–2027

14.2.1. Uncomplicated Gonococcal Infection

14.2.2. Gonococcal Arthritis

14.2.3. Gonococcal Meningitis and Endocarditis

14.3. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Treatment, 2017–2027

14.3.1. Monotherapy

14.3.2. Dual Therapy

14.4. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017–2027

14.4.1. Oral

14.4.2. Injectable

14.5. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Gender, 2017–2027

14.5.1. Women

14.5.2. Men

14.6. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017–2027

14.6.1. Hospital Pharmacies

14.6.2. Retail Pharmacies

14.6.3. Online Pharmacies

14.6.4. Others

14.7. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Country/Sub-region, 2017–2027

14.7.1. China

14.7.2. Japan

14.7.3. India

14.7.4. Australia & New Zealand

14.7.5. Rest of Asia Pacific

14.8. Asia Pacific Gonorrhea Therapeutics Market Attractiveness Analysis

14.8.1. By Gonococcal Infection Type

14.8.2. By Treatment

14.8.3. By Route of Administration

14.8.4. By Gender

14.8.5. By Distribution Channel

14.8.6. By Country/Sub-region

15. Latin America Gonorrhea Therapeutics Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Latin America Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017–2027

15.2.1. Uncomplicated Gonococcal Infection

15.2.2. Gonococcal Arthritis

15.2.3. Gonococcal Meningitis and Endocarditis

15.3. Latin America Gonorrhea Therapeutics Market Forecast, by Treatment, 2017–2027

15.3.1. Monotherapy

15.3.2. Dual Therapy

15.4. Latin America Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017–2027

15.4.1. Oral

15.4.2. Injectable

15.5. Latin America Gonorrhea Therapeutics Market Forecast, by Gender, 2017–2027

15.5.1. Women

15.5.2. Men

15.6. Latin America Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017–2027

15.6.1. Hospital Pharmacies

15.6.2. Retail Pharmacies

15.6.3. Online Pharmacies

15.6.4. Others

15.7. Latin America Gonorrhea Therapeutics Market Forecast, by Country/Sub-region, 2017–2027

15.7.1. Brazil

15.7.2. Mexico

15.7.3. Rest of Latin America

15.8. Latin America Gonorrhea Therapeutics Market Attractiveness Analysis

15.8.1. By Gonococcal Infection Type

15.8.2. By Treatment

15.8.3. By Route of Administration

15.8.4. By Gender

15.8.5. By Distribution Channel

15.8.6. By Country/Sub-region

16. Middle East & Africa Gonorrhea Therapeutics Market Analysis and Forecast

16.1. Introduction

16.1.1. Key Findings

16.2. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017–2027

16.2.1. Uncomplicated Gonococcal Infection

16.2.2. Gonococcal Arthritis

16.2.3. Gonococcal Meningitis and Endocarditis

16.3. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Treatment, 2017–2027

16.3.1. . Monotherapy

16.3.2. Dual Therapy

16.4. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017–2027

16.4.1. Oral

16.4.2. Injectable

16.5. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Gender, 2017–2027

16.5.1. Women

16.5.2. Men

16.6. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017–2027

16.6.1. Hospital Pharmacies

16.6.2. Retail Pharmacies

16.6.3. Online Pharmacies

16.6.4. Others

16.7. Middle East & Africa Gonorrhea Therapeutics Market Forecast by Country/Sub-region, 2017–2027

16.7.1. GCC Countries

16.7.2. South Africa

16.7.3. Israel

16.7.4. Rest of Middle East & Africa

16.8. Middle East & Africa Gonorrhea Therapeutics Market Attractiveness Analysis

16.8.1. By Gonococcal Infection Type

16.8.2. By Treatment

16.8.3. By Route of Administration

16.8.4. By Gender

16.8.5. By Distribution Channel

16.8.6. By Country/Sub-region

17. Competition Landscape

17.1. Market Player – Competition Matrix (by Tier and Size of companies)

17.2. Market Share Analysis by Company (2018)

17.3. Company Profiles

17.3.1. GlaxoSmithKline plc.

17.3.1.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.1.2 Financial Overview

17.3.1.3 SWOT Analysis

17.3.1.4 Strategic Overview

17.3.2. Merck & Co., Inc.

17.3.2.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.2.2 Financial Overview

17.3.2.3 SWOT Analysis

17.3.2.4 Strategic Overview

17.3.3. Pfizer Inc.

17.3.3.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.3.2 Financial Overview

17.3.3.3 SWOT Analysis

17.3.3.4 Strategic Overview

17.3.4. AstraZeneca

17.3.4.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.4.2 Financial Overview

17.3.4.3 SWOT Analysis

17.3.4.4 Strategic Overview

17.3.5. Hologic, Inc.

17.3.5.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.5.2 Financial Overview

17.3.5.3 SWOT Analysis

17.3.5.4 Strategic Overview

17.3.6. Danaher

17.3.6.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.6.2 Financial Overview

17.3.6.3 SWOT Analysis

17.3.6.4 Strategic Overview

17.3.7. Abbott

17.3.7.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.7.2 Financial Overview

17.3.7.3 SWOT Analysis

17.3.7.4 Strategic Overview

17.3.8. Becton Dickinson and Company

17.3.8.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.8.2 Financial Overview

17.3.8.3 SWOT Analysis

17.3.8.4 Strategic Overview

17.3.9. F. Hoffmann-La Roche Ltd

17.3.9.1 Company Overview (Headquarters, Business Segments, Employee Strength)

17.3.9.2 Financial Overview

17.3.9.3 SWOT Analysis

17.3.9.4 Strategic Overview

17.3.10. Other Prominent Key Players

*Note: Financial details for companies that do not report this information in public domain might not be captured.

List of Tables

Table 1: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017–2027
Table 2: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 3: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 4: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017–2027
Table 5: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 6: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017–2027
Table 7: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 8: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 9: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017–2027
Table 10: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 11: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017–2027
Table 12: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 13: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 14: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017–2027
Table 15: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 16: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017–2027
Table 17: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 18: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 19: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017–2027
Table 20: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 21: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017–2027
Table 22: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 23: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 24: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017–2027
Table 25: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 26: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017–2027
Table 27: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 28: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 29: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017–2027
Table 30: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027